Rating #33
Chris Davis
Davis Selected Advisers
Portfolio value
Stocks
Performance
1 Year
+17.56%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Chris Davis’ Portfolio: Q1 2026
Top10 stocks: 47.30% of the portfolio
Chris Davis’ Trades: Q1 2026
Adds
New Buys
Sold Outs
Cuts
1.80ppt
1.40ppt
0.45ppt
2.14ppt
0.25ppt
-0.13ppt
0.19ppt
-0.14ppt
0.03ppt
0.47ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  CI | Add +196.73% | $276.68 | $409.78M | 1.80ppt | |
2  JBS | Add +121.39% | $15.57 | $224.05M | 1.40ppt | |
3  SE | Add +323.75% | $107.18 | $151.48M | 0.45ppt | |
4  CTRA | Add +14.08% | $30.06 | $137.73M | 2.14ppt | |
5  YMM | Add +64.01% | $9.51 | $106.76M | 0.25ppt | |
6  TCOM | Add +29.72% | $58.29 | $87.54M | -0.13ppt | |
7  SAP | Add +463.33% | $206.39 | $53.88M | 0.19ppt | |
8  APP | Add +35.42% | $483.34 | $42.45M | -0.14ppt | |
9  RKT | Add +49.43% | $18.19 | $29.03M | 0.03ppt | |
10  TSN | Add +2.05% | $62.09 | $16.34M | 0.47ppt |
Chris Davis’ Holdings: Q1 2026
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1  COF | National Banks | $82.71 | Cut -0.87% | 8.54M | $1.56B | 7.15% -2.23ppt | 1.58% | 47 Quarters | Q1 2026 | |
2 CTRA | Crude Oil & Gas | $26.41 | Add +14.08% | 37.12M | $1.30B | 5.99% 2.14ppt | 4.88% | 4 Quarters | Q1 2026 | |
3  USB | National Banks | $44.58 | Add +0.89% | 22.24M | $1.16B | 5.31% 0.02ppt | 1.43% | 65 Quarters | Q1 2026 | |
4  VTRS | Pharmaceutical Pres | $13.01 | Add +0.04% | 78.21M | $1.06B | 4.85% 0.48ppt | 6.79% | 22 Quarters | Q1 2026 | |
5  META | Computer Programming & Data | $150.74 | Cut -1.93% | 1.72M | $983.59M | 4.52% -0.69ppt | 0.07% | 42 Quarters | Q1 2026 | |
6  MGM | Hotels & Motels | $37.56 | Cut -9.41% | 24.30M | $899.17M | 4.13% -0.27ppt | 9.17% | 11 Quarters | Q1 2026 | |
Computer Programming & Data | $71.03 | Cut -0.77% | 3.09M | $889.90M | 4.09% -0.30ppt | 0.03% | 42 Quarters | Q1 2026 | ||
8  CVS | Retail-Drug Stores | $49.39 | Cut -4.08% | 12.24M | $879.05M | 4.04% -0.52ppt | 0.97% | 30 Quarters | Q1 2026 | |
9 TSN | Poultry Processing | $57.86 | Add +2.05% | 13.09M | $838.72M | 3.85% 0.47ppt | 3.79% | 8 Quarters | Q1 2026 | |
10  MKL | Casualty Insurance | $1129.73 | Cut -7.64% | 383.43K | $733.96M | 3.37% -0.64ppt | 3.02% | 88 Quarters | Q1 2026 | |
11  AMZN | Retail-Catalog & Mail-Order | $60.34 | Cut -0.12% | 3.43M | $713.38M | 3.28% -0.28ppt | 0.03% | 85 Quarters | Q1 2026 | |
12  BRK.A | Casualty Insurance | $122960.04 | Cut -2.12% | 923.00 | $662.84M | 3.04% -0.16ppt | 0.06% | 83 Quarters | Q1 2026 | |
13  WFC | National Banks | $31.67 | Cut -0.81% | 8.19M | $652.08M | 2.99% -0.47ppt | 0.26% | 88 Quarters | Q1 2026 | |
14 CI | Medical Service Plans | $248.73 | Add +196.73% | 2.23M | $595.91M | 2.74% 1.80ppt | 0.84% | 30 Quarters | Q1 2026 | |
15  TXN | Semiconductors | $62.06 | Cut -0.12% | 2.85M | $553.24M | 2.54% 0.32ppt | 0.31% | 79 Quarters | Q1 2026 | |
16  TECK | Diversified Metals and Mining | $30.39 | Cut -11.94% | 10.58M | $547.76M | 2.51% -0.07ppt | 2.17% | 19 Quarters | Q1 2026 | |
17 JBS | Meat Packing | $16.36 | Add +121.39% | 26.24M | $471.35M | 2.16% 1.40ppt | 2.46% | 2 Quarters | Q1 2026 | |
18  LYB | Organic Chemicals | $80.56 | New Buy +100.00% | 5.60M | $450.86M | 2.07% 2.07ppt | 1.74% | 1 Quarter | Q1 2026 | |
19  SOLV | Surgical Instruments | $56.12 | Add +1.77% | 6.33M | $413.37M | 1.90% -0.32ppt | 3.64% | 8 Quarters | Q1 2026 | |
20  AMAT | Semiconductors | $74.75 | Cut -71.51% | 1.20M | $409.16M | 1.88% -2.97ppt | 0.15% | 58 Quarters | Q1 2026 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.